Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.
about
Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment.Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer.Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancerBaseline neutrophil-lymphocyte ratio (≥2.8) as a prognostic factor for patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiationDensity of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer.Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsetsThe pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis.Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinomaTreatment of locally advanced rectal cancer: controversies and questions.Predictive value of pretreatment lymphocyte count in stage II colorectal cancer and in high-risk patients treated with adjuvant chemotherapy.Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapyPre-operative Neutrophils/Lymphocyte Ratio in Rectal Cancer Patients with Preoperative ChemoradiotherapyThe preoperative platelet to lymphocyte ratio is a prognostic marker in patients with stage II colorectal cancer.Clinical and molecular diagnosis of pathologic complete response in rectal cancer.Prognostic value of pretreatment peripheral blood markers in paranasal sinus cancer: Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio.Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy?Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.Intratumoral injection of interleukin-2 augments the local and abscopal effects of radiotherapy in murine rectal cancer.Neoadjuvant chemoradiotherapy of rectal carcinoma : Baseline hematologic parameters influencing outcomes.Identification of the prognostic value of lymphocyte-to-monocyte ratio in patients with HBV-associated advanced hepatocellular carcinoma.Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients.The lymphocyte-monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy.Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer.Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer.Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma.Combination of the neutrophil to lymphocyte ratio and the platelet to lymphocyte ratio as a useful predictor for recurrence following radiofrequency ablation of hepatocellular carcinoma.Prognostic significance of neoadjuvant rectal score in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and construction of a prediction model.The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine.Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.Pretreatment levels of peripheral neutrophils and lymphocytes as independent prognostic factors in patients with nasopharyngeal carcinoma.Clinicopathological and prognostic significance of high circulating lymphocyte ratio in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.Elevated preoperative neutrophil-to-lymphocytes ratio predicts poor prognosis after esophagectomy in T1 esophageal cancer.Sustaining Blood Lymphocyte Count during Preoperative Chemoradiotherapy as a Predictive Marker for Pathologic Complete Response in Locally Advanced Rectal Cancer.Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer.Temporal changes in immune cell composition and cytokines in response to chemoradiation in rectal cancer.Mean Corpuscular Volume as a Predictive Factor of Response to Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer.Absolute Lymphocyte Count in Preoperative Chemoradiotherapy for Rectal Cancer: Changes Over Time and Prognostic Significance.Association between Neutrophil-to-Lymphocyte Ratio and Gut Microbiota in a Large Population: a Retrospective Cross-Sectional Study
P2860
Q33395123-8E8E370C-D0F7-4EED-8834-4E06E5F3B0D7Q33834316-2A5A13A6-60D6-40FD-88C4-6D177CD60D93Q34566054-FD258C76-873A-421F-9784-C783AC244947Q34989484-E4D49C9C-6872-45A0-9194-95324A21017FQ35061159-00D54C49-D0A9-4996-B989-BDB0207D2A6DQ35083126-E644B245-6BFF-4A70-9405-B8C13A7DAB47Q36252250-A18C1CA8-4BEB-4E64-83F2-F41BE9B7FABDQ36290407-AC7D94D5-6F04-4CA4-BA0B-E1A715B7A11EQ36301765-0929FF41-4702-4709-B349-70860CA0872EQ36351882-2923F61A-2A42-415B-B667-0E6FD5653F50Q36729590-145F6F54-CD5B-4CD6-A539-27A4FEDD49C5Q37106318-D922D730-FE6A-475C-9FB1-BE2FAFB7ECE2Q37279883-257B46BF-0367-4B42-A6D1-E6A330910024Q38518401-48603F80-1B0D-4D3F-8CA7-2B7297186001Q38594617-16C2D12A-F103-488C-A220-40428A280138Q39062109-C841A085-DB46-45BC-88F2-425EB98E9375Q39187442-383500A8-AB6F-4E04-8C38-6E368044EF2EQ39277599-14B08C69-E17A-4531-B5BC-48A1114A10DCQ39569395-CB218CC2-107D-4048-BFC3-794E72002D85Q39703037-1F84FE1D-D00B-413A-86F7-FD102D4686ACQ40044138-2F352059-158C-4328-A66B-F065672F9A47Q40877283-52D0C456-5950-45B6-B86D-7EF75CE34D79Q42161730-B085A1A9-EC58-4024-A5B0-9CACED9B87F5Q47108227-3D410420-E28D-4DAE-9C75-9DD00DA13DB4Q47136840-9F0F7431-D80E-490D-A545-03E806BBAD7AQ47143987-84FA45E9-8605-4E7A-806F-90836FCA3500Q47147429-3CCF2C12-99AC-425B-A7DC-81D95AADB16EQ47580220-822E4C1F-1C98-445A-A36C-8F5430118389Q48283608-92CC6DCF-AAA8-472A-8986-6E4096C74BAEQ49191186-82E898B6-9A2E-4FB0-B1DF-24D85CE8ACC8Q50967431-2C0D2CE9-AB48-4AF1-905C-C1D31844EE0DQ52718458-93CEF081-9ACC-4703-A61F-4EC78BC5C7EAQ52925618-DF425142-C423-471C-8F63-C2DBF685FCFBQ53229332-796488FC-2EDC-4551-B182-AE4554AD0E38Q53244866-556E715F-7E25-4101-BA04-C20F7C97E6FFQ54958909-681C6CA9-4AAB-426A-9688-6A39E12AF0B8Q55233773-225F1806-AE89-4A91-B3E6-5CD9155C6798Q55514995-C40DCF09-7137-4EB2-AECC-2ECF2FF5CA44Q58099014-D52019A7-DD06-4FCA-A92C-E7F390E9AA7A
P2860
Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Circulating lymphocyte number ...... py for advanced rectal cancer.
@ast
Circulating lymphocyte number ...... py for advanced rectal cancer.
@en
type
label
Circulating lymphocyte number ...... py for advanced rectal cancer.
@ast
Circulating lymphocyte number ...... py for advanced rectal cancer.
@en
prefLabel
Circulating lymphocyte number ...... py for advanced rectal cancer.
@ast
Circulating lymphocyte number ...... py for advanced rectal cancer.
@en
P2093
P2860
P356
P1433
P1476
Circulating lymphocyte number ...... py for advanced rectal cancer.
@en
P2093
Eiji Sunami
Hirokazu Nagawa
Joji Kitayama
Kazushige Kawai
Koji Yasuda
P2860
P2888
P356
10.1186/1748-717X-5-47
P577
2010-06-03T00:00:00Z
P6179
1002345081